Ge Long Hui·2025-11-10 12:35Core Viewpoint - The chairman of Junshi Biosciences, Xiong Jun, plans to increase his stake in the company by at least RMB 100 million over the next 12 months, starting from April 12, 2025, indicating confidence in the company's future performance [1] Group 1: Shareholding Plan - Xiong Jun intends to purchase both A-shares and H-shares, with a minimum of RMB 50 million allocated for A-shares [1] - As of the announcement date, Xiong Jun has already acquired 100,000 A-shares through the Shanghai Stock Exchange, representing approximately 0.01% of the company's total share capital, with a total transaction amount of RMB 3.8384 million [1] - The share purchase plan is still ongoing, and Xiong Jun will continue to buy shares as per the outlined plan during the implementation period [1]